These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6202667)

  • 1. Synergistic effect of peplomycin in combination with bleomycin on L5178y mouse lymphoma cells in vivo.
    Müller WE; Zahn RK; Maidhof A; Schröder HC; Bachmann M; Umezawa H
    J Antibiot (Tokyo); 1984 Mar; 37(3):239-43. PubMed ID: 6202667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the cytostatic effect of bleomycin on L5178y mouse lymphoma cells by pepleomycin.
    Müller WE; Geisert M; Zahn RK; Maidhof A; Bachmann M; Umezawa H
    Eur J Cancer Clin Oncol; 1983 May; 19(5):665-70. PubMed ID: 6191987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary toxicity of the combination of bleomycin and peplomycin--an experimental study in rats.
    Mall G; Burkhardt A
    Cancer Chemother Pharmacol; 1991; 28(5):357-60. PubMed ID: 1717172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of repair of bleomycin-induced DNA strand breaks by 2'-deoxycoformycin and its effect on antitumor activity in L5178Y lymphoblasts.
    Begleiter A; Peniuk H; Israels LG; Johnston JB
    Biochem Pharmacol; 1992 Dec; 44(11):2229-33. PubMed ID: 1282003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental studies on combination chemotherapy of cisplatin with peplomycin against human squamous cell carcinomas in nude mice].
    Ekimoto H; Aikawa M; Takahashi K; Matsuda A
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):70-6. PubMed ID: 2578275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of bleomycin cytotoxicity by polyhydric alcohols.
    Suzuki T; Kohda K; Kawazoe Y
    Anticancer Res; 1990; 10(1):97-103. PubMed ID: 1692198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytostatic and cytotoxic response of Ehrlich ascites tumor cells in vivo on chronic treatment with cytarabine, bleomycin, and peplomycin.
    Stoehr M; Friedel G; Engel P; Goerttler K; Futterman G
    Arzneimittelforschung; 1984; 34(4):451-4. PubMed ID: 6204650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity of bleomycin sulfate and peplomycin sulfate after repeated subcutaneous application to rats.
    Habs M; Schmähl D
    Oncology; 1984; 41(2):114-9. PubMed ID: 6200809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of transport of bleomycin and cobalt-bleomycin in L5178Y cells.
    Uehara Y; Hori M; Umezawa H
    Biochem Biophys Res Commun; 1982 Jan; 104(2):416-21. PubMed ID: 6176230
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytostatic activity of aeroplysinin-1 against lymphoma and epithelioma cells.
    Kreuter MH; Bernd A; Holzmann H; Müller-Klieser W; Maidhof A; Weissmann N; Kljajić Z; Batel R; Schröder HC; Müller WE
    Z Naturforsch C J Biosci; 1989; 44(7-8):680-8. PubMed ID: 2673260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced pulmonary toxicity of peplomycin in a new drug-delivery system.
    Hagiwara A; Takahashi T; Ueda T; Torii T
    Anticancer Drug Des; 1988 Mar; 2(4):319-24. PubMed ID: 2452644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between 5-fluoro-2'-deoxyuridine and 5-fluorouridine in their cytotoxic effect on growth of murine lymphoma L5178Y cells in in vivo and in vitro systems.
    Kanzawa F; Hoshi A; Kuretani K
    Eur J Cancer (1965); 1980 Aug; 16(8):1087-92. PubMed ID: 6449368
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fundamental study on the combination therapy of cisplatin and peplomycin].
    Fujii M
    Nihon Jibiinkoka Gakkai Kaiho; 1985 Apr; 88(4):512-9. PubMed ID: 2411899
    [No Abstract]   [Full Text] [Related]  

  • 14. Peplomycin and liblomycin, a new analogues of bleomycin.
    Takita T; Ogino T
    Biomed Pharmacother; 1987; 41(5):219-26. PubMed ID: 2444281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA; Morgenstern B; Capizzi RL
    Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of filipin, a polyene antibiotic, on human tumor cell killing in vitro by peplomycin].
    Urade M; Sugi M; Igarashi T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3244-50. PubMed ID: 2430525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two types of lethal damage induced by pepleomycin in cultured Chinese hamster V79 cells.
    Saito T; Kamata R; Okada S
    Gan; 1984 Feb; 75(2):143-50. PubMed ID: 6203804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modification of the cytotoxic effect of peplomycin by cepharanthine].
    Hashiba M; Yamashita M; Murakami K; Nishikawa H
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3245-51. PubMed ID: 2446565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell killing mode of liblomycin (NK313), a novel dose-survival relationship different from bleomycins.
    Kuramochi-Motegi A; Kuramochi H; Takahashi K; Takeuchi T
    J Antibiot (Tokyo); 1991 Apr; 44(4):429-34. PubMed ID: 1709630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal effect of bleomycin and peplomycin on HeLa cells in multicell tumor spheroids.
    Sasaki T; Yamamoto M; Kuwahara K
    Cancer Res; 1984 Apr; 44(4):1374-9. PubMed ID: 6200210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.